FI911973A0 - Traodaktigt hemagglutinin av b. pertussis-bacill. - Google Patents

Traodaktigt hemagglutinin av b. pertussis-bacill.

Info

Publication number
FI911973A0
FI911973A0 FI911973A FI911973A FI911973A0 FI 911973 A0 FI911973 A0 FI 911973A0 FI 911973 A FI911973 A FI 911973A FI 911973 A FI911973 A FI 911973A FI 911973 A0 FI911973 A0 FI 911973A0
Authority
FI
Finland
Prior art keywords
pertussis
hemagglutinin
traodaktigt
bacill
therapy
Prior art date
Application number
FI911973A
Other languages
English (en)
Inventor
David A Relman
Mario Domenighini
Rino Rappuoli
Stanley Falkow
Original Assignee
Univ Leland Stanford Junior
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Sclavo Spa filed Critical Univ Leland Stanford Junior
Publication of FI911973A0 publication Critical patent/FI911973A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
  • Insulated Conductors (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI911973A 1988-10-27 1991-04-23 Traodaktigt hemagglutinin av b. pertussis-bacill. FI911973A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26364888A 1988-10-27 1988-10-27
PCT/US1989/004732 WO1990004641A1 (en) 1988-10-27 1989-10-20 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS)

Publications (1)

Publication Number Publication Date
FI911973A0 true FI911973A0 (fi) 1991-04-23

Family

ID=23002666

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911973A FI911973A0 (fi) 1988-10-27 1991-04-23 Traodaktigt hemagglutinin av b. pertussis-bacill.

Country Status (9)

Country Link
EP (1) EP0439542B1 (fi)
JP (1) JPH04501506A (fi)
AT (1) ATE176913T1 (fi)
AU (1) AU643190B2 (fi)
CA (1) CA1341123C (fi)
DE (1) DE68928933T2 (fi)
DK (1) DK76191A (fi)
FI (1) FI911973A0 (fi)
WO (1) WO1990004641A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643753A (en) 1990-04-18 1997-07-01 Connaught Laboratories Limited Use of autologous promoters to express gene products in bordetella
GB9008746D0 (en) * 1990-04-18 1990-06-13 Connaught Lab The use of autologous promoters to express gene products in bordetella
DE4111531A1 (de) * 1991-04-09 1992-10-29 Biotechnolog Forschung Gmbh Plasmide zur fha-expression und wirte
WO1994021816A1 (en) * 1993-03-25 1994-09-29 Envirocon International Incorporated Test kits and methods for rapidly testing for contamination by microorganisms
US5646251A (en) * 1993-11-05 1997-07-08 The Board Of Trustees Of Leeland Stanford Jr. Univ. Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
EP1069133A1 (en) 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis compounds and anti-infection applications thereof
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine

Also Published As

Publication number Publication date
ATE176913T1 (de) 1999-03-15
EP0439542A4 (en) 1991-11-06
JPH04501506A (ja) 1992-03-19
WO1990004641A1 (en) 1990-05-03
AU643190B2 (en) 1993-11-11
DK76191D0 (da) 1991-04-25
EP0439542A1 (en) 1991-08-07
DE68928933D1 (de) 1999-04-01
CA1341123C (en) 2000-10-17
EP0439542B1 (en) 1999-02-24
DE68928933T2 (de) 1999-08-26
AU4515589A (en) 1990-05-14
DK76191A (da) 1991-06-14

Similar Documents

Publication Publication Date Title
IT8224948A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
IT8419729A0 (it) Procedimento per la preparazione di vaccini polivalenti adsorbiti liofilizzati.
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
DE3485267D1 (de) Herstellung von streptokokken-m-protein-immunogenen und molekularen sonden.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
NO904471D0 (no) Fremgangsmaate for fremstilling av partikkelformig titandioxyd.
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO904877L (no) Fremgangsmaate for fremstilling av titandioxyd.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
FI911973A0 (fi) Traodaktigt hemagglutinin av b. pertussis-bacill.
NO895012L (no) Fremgangsmaate for fremstilling av varige titandioxydpigmenter.
DE69017608D1 (de) Verfahren für die Bestimmung von Distickstoffoxid.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
DE68914042D1 (de) Verfahren zur Herstellung von Polyfluorokohlenwasserstoffiodid.
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
NO901505D0 (no) Fremgangsmaate for fremstilling av titandioksyd.
DE68912734D1 (de) Verfahren zur Herstellung von Tetrafluoräthylen.
HU9200583D0 (en) Method for producing el peptides of rubeola
IT8049346A0 (it) Composizione antigene relativo vaccino e procedimento di produzione
NO912823L (no) Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette.
DK0809653T3 (da) Helicobacter pylori-antigen
NO864382D0 (no) Midler for forbedring av proteinabsorpsjon.
IT1213576B (it) Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.